- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - https://eyedocnews.com -

Early Positive Results in Ongoing Gene Therapy Trials for Wet AMD and Stargardt’s

Posted By Irv Arons On August 16, 2012 @ 5:30 am In Clinical Trials,Industry News,Macular Degeneration,NeuroOphthalmology,New Technologies,Research,Retina,Stem Cell Therapies | Comments Disabled

Last week, Oxford BioMedica and its partner Sanofi announced positive results in their ongoing gene therapy clinical trials for wet AMD and Stargardt’s disease. In an interim review of their Phase I (RetinoStat) and Phase I/IIa (StarGen) trials, the Data Safetly Monitoring Board (DSMB), an independent panel of specialists in the fields of ophthalmology, virology and vectorology, gave the go ahead to proceed to a final patient cohort in the Phase I study in the case of the RetinoStat trial, and to a third patient cohort in the Phase I/IIa study of the StarGen trial.

To read more about the status of these clinical trials, please follow this link [1].


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: https://eyedocnews.com

URL to article: https://eyedocnews.com/006852-early-positive-results-in-ongoing-gene-therapy-for-wet-amd-and-stargardts/

URLs in this post:

[1] link: http://tinyurl.com/GeneTherapyUpdate14

Copyright © 2008 Eye Doc Talk. All rights reserved.